0001849521-24-000004.txt : 20240603 0001849521-24-000004.hdr.sgml : 20240603 20240603173057 ACCESSION NUMBER: 0001849521-24-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240531 FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandford Nicole CENTRAL INDEX KEY: 0001849521 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 241015120 BUSINESS ADDRESS: BUSINESS PHONE: 203-969-5688 MAIL ADDRESS: STREET 1: 12117 BEE CAVES RD BLDG 3 STREET 2: STE 100 CITY: AUSTIN STATE: TX ZIP: 78738 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2024-05-31 0 0000926617 Aspira Women's Health Inc. AWH 0001849521 Sandford Nicole C/O ASPIRA WOMEN'S HEALTH INC. 12117 BEE CAVES RD BLDG 3-100 AUSTIN TX 78738 1 1 0 0 Chief Executive Officer 0 Common Stock 2024-05-31 4 P 0 9493 2.42 A 70596 D The purchase reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.34 to $2.45 per share. The reporting person undertakes to provide to AWH, any security holder of AWH or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. /s/ Nicole Sandford 2024-06-03